Skip to main content
Log in

Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: A statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The prognostic value of immunosuppressive acidic protein (IAP), which is known to suppress various immune responses in cancer patients, was studied in a prospective randomized trial of advanced gastric cancer patients, designed to evaluate the effect of PSK, a kind of biological response modifier with protein-bound polysaccharides. Preoperative serum IAP levels were determined in 228 patients who received radical gastric resection and tests conducted in one laboratory by the single radial immunodiffusion (SRID) method. All patients were followed up for 24 months or more. There was an overall significant difference in disease-free survival time in favour of the PSK-treated group compared with the control group. Preoperative IAP values were strongly associated with disease-free survival time. The statistical analysis to define an appropriate cut-off level for IAP was performed using Cox's proportional hazards model. The most significant difference was observed at the threshold value of 580 μg/ml, the hazard ratio being 2.13 with a 95% confidence interval [1.17, 3.88] (P=0.013). Patients in the PSK-treated group with a preoperative IAP of lower than 580 μg/ml showed improved disease-free survival (P=0.029), however, no significant difference was seen between the two groups when the preoperative IAP exceeded the threshold level. From these results, 580 μg/ml is postulated to be the most appropriate threshold value for predicting the prognosis of advanced gastric cancer patients, and it is suggested that PSK would be most effective in patients whose preoperative IAP level is lower than the threshold level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tamura K, Shibata Y, Matsuda Y, Ishida N (1981) Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients. Cancer Res 41:3244–3252

    Google Scholar 

  2. Shibata Y, Tamura K, Ishida N (1983) In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alfa-1 acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res 43:2889–2896

    Google Scholar 

  3. Chandrasekaran EV, Davila M, Nixon D, Mendicino J (1984) Structures of the oligosaccharide chains of two forms of alfa-1 acid glycoprotein purified from liver metastasis of lung, colon and breast tumors. Cancer Res 44:1557–1567

    Google Scholar 

  4. Yamanaka N, Harabuchi Y, Himi T, Kataura A (1988) Immunosuppressive substance in the sera of head and neck cancer patients. Cancer 62:1293–1298

    Google Scholar 

  5. Sawada M, Okudaira Y, Matsui Y, Shimizu Y (1983) Immunosuppressive acidic protein in patients with ovarian cancer. Cancer 52:2081–2085

    Google Scholar 

  6. Sakita M, Torii T, Imaki S, Kasuga M, Tamai M, Suzuki G, Kano M, Fujita Y, Majima S (1984) Immunosuppressive activity of sera from gastric cancer patients. Jpn J Surg 14(2):127–134

    Google Scholar 

  7. Mancini G, Garbonara AO, Hermans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235–254

    Google Scholar 

  8. Saji S, Yokoyama Y, Niwa H, Takao H, Kida H, Kawata R, Tanemura H, Sakata K (1986) Clinical studies on serum immunosuppressive acidic protein (IAP) and ferritin in gastric cancer patients: With special reference to preoperative value and influence of surgical stress. J Surg Oncol 33:215–222

    Google Scholar 

  9. Kohgo Y, Sakamaki S, Niitsu Y (1989) Nonspecific humoral immunosuppressive factors with special reference to immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS). Biotherapy 3(2):469–477

    Google Scholar 

  10. Akiyama J, Kawamura T, Gotohda E, Yamada Y, Hosokawa M, Kodama T, Kobayashi H (1977) Immunochemotherapy of transplanted KMT-17 tumor in WKA Ra by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from Basidiomycetes. Cancer Res 37:3042–3045

    Google Scholar 

  11. Toge T, Yamaguchi Y, Kegoya Y, Baba N, Yanagawa E, Hattori T (1989) Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSK. Int J Immunopharmacol 11:9–12

    Google Scholar 

  12. Hermanek P, Sobin LH (eds) (1987) International Union Against Cancer: TNM classification of malignant tumors, 4th edn. Springer Tokyo, pp 43–46

  13. Nakazato H, Koike A, Ichihashi H, Saji S, Danno M, Ogawa N (1989) An effect of adjuvant immunochemotherapy using Krestin and 5-FU on gastric cancer patients with radical surgery — A randomized controlled trial by the cooperative study group. Jpn J Cancer Chemother 16(8):2563–2576. (In Japanese)

    Google Scholar 

  14. Cox DR (1972) Regression models and life-tables. J R Stat Soc (B) 34:187–220

    Google Scholar 

  15. Kalbfleisch JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley and Sons, New York

    Google Scholar 

  16. Miwa K, The Japanese Research Society for Gastric Cancer (1984) Evaluation of the TNM Classification of stomach cancer and proposal for its rational stage-grouping. Jpn J Clin Oncol 14(3):385–410

    Google Scholar 

  17. Young FW, Takane Y, Leeuw J (1978) The principal components of mixed measurement level multivariate data — An alternating least square method with optimal scaling features. Psychometrika 43:279–281

    Google Scholar 

  18. Beutler B, Cerami A (1986) Cachectin and tumor necrosis factors as two sides of the same biological coin. Nature 320:584–588

    Google Scholar 

  19. Toh H, Hayashida H, Kikuno R, Yasunaga T, Miyata T (1985) Sequence similarity between EGF receptor and α-1 acid glycoprotein. Nature 314:199–200

    Google Scholar 

  20. Schmidt K, Kaufmann H, Isemura S, Bauer F, Emura J, Motoyama T, Ishiguro M, Nanno S (1973) Structure of α-1 acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins. Biochemistry 12:2711–2724

    Google Scholar 

  21. Chu C, Lai L TY, Pokala HP (1982) Value of plasma alfa-1 acid glycoprotein assay in the detection of human colorectal cancer — Comparison with carcinoembryonic antigen. JNCI 68:75–79

    Google Scholar 

  22. Yamashita K, Hayashi H, Mure K, Ishikawa M, Shimizu T (1986) Serum immunosuppressive substance in patients with gynecologic malignancies and in pregnant women. Cancer 57:69–74

    Google Scholar 

  23. Gahmberg CG, Andersson LC (1987) Leucocyte surface origin of human α-1 acid glycoprotein (Orosomucoid). J Exp Med 148(2):507–521

    Google Scholar 

  24. Aozasa K, Ueda T, Ayata M, Tsujimoto M, Fujita M, Yamamura T, Tsujimura T (1987) Immunohistochemical determination of immunosuppressive acid protein in reactive and neoplastic disease of macrophage. Cancer 60:2424–2427

    Google Scholar 

  25. Urushizaki I, Ishitani K, Nagai T, Gocho Y, Koyama R (1977) Immunosuppressive factors in serum of patients with gastric carcinoma. Gann 68:413–421

    Google Scholar 

  26. Kondo T, Sakamoto J, Ichihashi H, Kamei H (1981) Effect of alternating administration of PSK and Carbazilquinone in tumor-bearing mice. Gann 72:293–299

    Google Scholar 

  27. Yoshikumi C, Nomoto K, Matsunaga K, Fujii T, Takeya K (1975) Mouse strain difference in the expression of antitumor activity of PS-K. Gann 66:649–654

    Google Scholar 

  28. Nomoto K, Yoshikumi C, Matsunaga K, Fujii T, Takeya K (1975) Restoration of antibody-forming capacities by PS-K in tumor-bearing mice. Gann 66:365–374

    Google Scholar 

  29. Fujii M, Fujii T, Saito K, Takahashi N, Yoshikumi C, Kakuchi J, Kawai Y (1987) Tumor growth promoting activity of an immunosuppressive substance and its modulation by protein-bound polysaccharide PSK. Immunol Lett 1987; 15:347–351

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakamoto, J., Koike, A., Saji, S. et al. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: A statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK. Surg Today 22, 530–536 (1992). https://doi.org/10.1007/BF00308899

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00308899

Key Words

Navigation